UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | I | K | L | M | N | O | P | R | S | T | U | V | W | Y | Z
Number of items: 222.


Abou-Sleiman, P; Vilarino-Guell, C; Quinn, NP; Bhatia, K; Lees, AJ; Martinez, M; Pankratz, N; (2006) Identifying genetic risk factors for idiopathic Parkinson's disease by combining genome-wide copy number variation data and published data from genome-wide sib-pair linkage studies. In: (pp. S548-S548).

Abou-Sleiman, PM; Hanna, MG; Wood, NW; (2006) Genetic association studies of complex neurological diseases. J NEUROL NEUROSUR PS , 77 (12) 1302 - 1304. 10.1136/jnnp.2005.082024.

Abou-Sleiman, PM; Muqit, MMK; McDonald, NQ; Yang, YX; Gandhi, S; Healy, DG; Harvey, K; (2006) A heterozygous effect for PINK1 mutations in Parkinson's disease? ANN NEUROL , 60 (4) 414 - 419. 10.1002/ana.20960.

Abou-Sleiman, PM; Muqit, MMK; McDonald, NQ; Yang, YX; Gandhi, S; Healy, DG; Harvey, K; (2006) A heterozygous effect for PINK1 mutations in Parkinson's disease? ANNALS OF NEUROLOGY , 60 (4) pp. 414-419. 10.1002/ana.20960.

Abou-Sleiman, PM; Muqit, MMK; Wood, NW; (2006) Expanding insights of mitochondrial dysfunction in Parkinson's disease. NAT REV NEUROSCI , 7 (3) 207 - 219. 10.1038/nrn1868.

Adighibe, O; Arepalli, S; Duckworth, J; Hardy, J; Wavrant-De Vrièze, F; (2006) Genetic variability at the LXR gene (NR1H2) may contribute to the risk of Alzheimer's disease. Neurobiol Aging , 27 (10) pp. 1431-1434. 10.1016/j.neurobiolaging.2005.08.010.

Avila, J; Nitsch, RM; Haass, C; De Strooper, B; (2006) European Alzheimer disease funding. Nat Med , 12 (7) pp. 776-777. 10.1038/nm0706-776.


Bandopadhyay, R; Coulter, I; Kumaran, R; Lashley, T; Kingsbury, A; de Silva, R; Holton, J; (2006) DJ-1 (PARK-7) protein in neuronal and glial inclusions in neurodegenerative disorders. In: NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. (pp. 221 - 221). BLACKWELL PUBLISHING

Bandopadhyay, R; Kingsbury, AE; Harvey, K; de Silva, R; Lees, AJ; (2006) Expression of LRRK2/dardarin and alpha-synuclein in Park8 mutated brains. In: MOVEMENT DISORDERS. (pp. S350 - S350). WILEY-LISS

Bentahir, M; Nyabi, O; Verhamme, J; Tolia, A; Horré, K; Wiltfang, J; Esselmann, H; (2006) Presenilin clinical mutations can affect gamma-secretase activity by different mechanisms. J Neurochem , 96 (3) pp. 732-742. 10.1111/j.1471-4159.2005.03578.x.

Berggren, U; Fahlke, C; Aronsson, E; Karanti, A; Eriksson, M; Blennow, K; Thelle, D; (2006) The taqI DRD2 A1 allele is associated with alcohol-dependence although its effect size is small. Alcohol Alcohol , 41 (5) pp. 479-485. 10.1093/alcalc/agl043.

Blazquez, L; Otaegui, D; Saenz, A; Paisan-Ruiz, C; Emparanza, JI; Ruiz-Martinez, J; Moreno, F; (2006) Apolipoprotein E epsilon 4 allele in familial and sporadic Parkinson's disease. NEUROSCI LETT , 406 (3) 235 - 239. 10.1016/j.neulet.2006.07.037.

Blennow, K; Zetterberg, H; (2006) Pinpointing plaques with PIB. Nat Med , 12 (7) pp. 753-754. 10.1038/nm0706-753.

Blennow, K; de Leon, MJ; Zetterberg, H; (2006) Alzheimer's disease. Lancet , 368 (9533) pp. 387-403. 10.1016/S0140-6736(06)69113-7.

Borhani Haghighi, A; Houlden, H; Lankarani, KB; Taghavi, A; Masnadi, K; Ashraf, AR; Safari, A; (2006) A novel DNA sequence variation in the first genetically confirmed allgrove syndrome in iran. J Clin Neuromuscul Dis , 7 (3) pp. 123-127. 10.1097/01.cnd.0000208261.93426.ab.

Bras, JM; Guerreiro, RJ; Morgadinho, AS; Januario, C; Oliveira, CR; Singleton, A; (2006) Genes and Parkinson's disease - A clinic-based study in a Portuguese cohort. In: MOVEMENT DISORDERS. (pp. S53 - S53). WILEY-LISS


Campbell, WA; Yang, H; Zetterberg, H; Baulac, S; Sears, JA; Liu, T; Wong, STC; (2006) Zebrafish lacking Alzheimer presenilin enhancer 2 (Pen-2) demonstrate excessive p53-dependent apoptosis and neuronal loss. J Neurochem , 96 (5) pp. 1423-1440. 10.1111/j.1471-4159.2006.03648.x.

Cano, SJ; Hobart, JC; Edwards, M; Fitzpatrick, R; Bhatia, K; Thompson, AJ; Warner, TT; (2006) CDIP-58 can measure the impact of botulinum toxin treatment in cervical dystonia. NEUROLOGY , 67 (12) 2230 - 2232.

Cardoso, F; Lees, AJ; (2006) Did Gustav Mahler have Sydenham's chorea? Mov Disord , 21 (3) pp. 289-292. 10.1002/mds.20788.

Caswell, R; Warner, T; Mehta, A; Ginsberg, L; (2006) POEMS syndrome. Practical Neurology , 6 (2) pp. 111-116. 10.1136/jnnp.2006.089003.

Caswell, R; Warner, TT; Mehta, A; Ginsberg, L; (2006) POEMS syndrome. Practical Neurology , 6 pp. 14-26.

Chegounchi, M; Hanna, MG; Neild, GH; (2006) Progressive neurological disease induced by tacrolimus in a renal transplant recipient: case presentation. BMC Nephrol , 7 7-. 10.1186/1471-2369-7-7. Gold open access

Chow, G; Beesley, CE; Robson, K; Winchester, BG; Holton, JL; (2006) Case of X-linked myopathy with excessive autophagy. J CHILD NEUROL , 21 (5) 431 - 433. 10.2310/7010.2006.00117.

Cipolat, S; Rudka, T; Hartmann, D; Costa, V; Serneels, L; Craessaerts, K; Metzger, K; (2006) Mitochondrial rhomboid PARL regulates cytochrome c release during apoptosis via OPA1-dependent cristae remodeling. Cell , 126 (1) pp. 163-175. 10.1016/j.cell.2006.06.021.

Clarimon, J; Scholz, S; Fung, H-C; Hardy, J; Eerola, J; Hellstrom, O; Chen, C-M; (2006) Conflicting results regarding the semaphorin gene (SEMA5A) and the risk for Parkinson disease. Am J Hum Genet , 78 (6) pp. 1082-1084. 10.1086/504727.

Cookson, MR; Hardy, J; (2006) The persistence of memory. N Engl J Med , 355 (25) pp. 2697-2698. 10.1056/NEJMcibr065999.

Cordivari, C; Misra, VP; Vincent, A; Catania, S; Bhatia, KP; Lees, AJ; (2006) Secondary nonresponsiveness to botulinum toxin a in cervical dystonia: The role of electromyogram-guided injections, botulinum toxin a antibody assay, and the extensor digitorum brevis test. MOVEMENT DISORD , 21 (10) 1737 - 1741. 10.1002/mds.21051.

Cordivari, C; Toms, N; Quinn, N; Bhatia, K; Lees, AJ; Brown, P; (2006) Neurophysiological characterisation of myoclonus dystonia. In: (pp. S419-S420).


Debrock, S; De Strooper, B; Vander Perre, S; Hill, JA; D'Hooghe, TM; (2006) Tumour necrosis factor-alpha, interleukin-6 and interleukin-8 do not promote adhesion of human endometrial epithelial cells to mesothelial cells in a quantitative in vitro model. Hum Reprod , 21 (3) pp. 605-609. 10.1093/humrep/dei375.

Djureinovic, T; Skoglund, J; Vandrovcova, J; Zhou, XL; Kalushkova, A; Iselius, L; Lindblom, A; (2006) A genome wide linkage analysis in Swedish families with hereditary non-familial adenomatous polyposis/non-hereditary non-polyposis colorectal cancer. GUT , 55 (3) 362 - 366. 10.1136/gut.2005.075333.

Duenas, AM; Goold, R; Giunti, P; (2006) Molecular pathogenesis of spinocerebellar ataxias. BRAIN , 129 1357 - 1370.

de Silva, R; Lashley, T; Strand, C; Shiarli, AM; Shi, J; Tian, JZ; Bailey, KL; (2006) An immunohistochemical study of cases of sporadic and inherited frontotemporal lobar degeneration using 3R-and 4R-specific tau monoclonal antibodies. ACTA NEUROPATHOL , 111 (4) 329 - 340. 10.1007/s00401-006-0048-x.

de Silva, R; Lashley, T; Strand, K; Shiarli, AM; Revesz, T; Mann, DMA; (2006) An immunohistochemical study of sporadic and inherited frontotemporal lobar degeneration using 3R-and 4R-specific monoclonal tau antibodies. In: NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. (pp. 235 - 235). BLACKWELL PUBLISHING


Edwards-Lee, T; Wen, J; Bell, J; Hardy, J; Chung, J; Momeni, P; (2006) A presenilin-1 mutation (T245P) in transmembrane domain 6 causes early onset Alzheimer's disease. Neurosci Lett , 398 (3) pp. 251-252. 10.1016/j.neulet.2006.01.006.

Elinder, F; Männikkö, R; Pandey, S; Larsson, HP; (2006) Mode shifts in the voltage gating of the mouse and human HCN2 and HCN4 channels. J Physiol , 575 (Pt 2) pp. 417-431. 10.1113/jphysiol.2006.110437.

Evans, AH; Lawrence, AD; Appel, S; Lees, AJ; (2006) Aversive off-symptoms in Parkinson patients compulsively using dopaminergic drugs: Drug reward can be punishing. In: (pp. S599-S599).

Evans, AH; Lawrence, AD; Potts, J; MacGregor, L; Katzenschlager, R; Shaw, K; Zijlmans, J; (2006) Relationship between impulsive sensation seeking traits, smoking, alcohol and caffeine intake, and Parkinson's disease. J NEUROL NEUROSUR PS , 77 (3) 317 - 321. 10.1136/jnnp.2005.065417.

Evans, AH; Pavese, N; Lawrence, AD; Tai, YF; Appel, S; Doder, M; Brooks, DJ; (2006) Compulsive drug use linked to sensitized ventral striatal dopamine transmission. Ann Neurol , 59 (5) pp. 852-858. 10.1002/ana.20822.


Fidani, L; Kalinderi, K; Bostantjopoulou, S; Clarimon, J; Goulas, A; Katsarou, Z; Hardy, J; (2006) Association of the Tau haplotype with Parkinson's disease in the Greek population. Mov Disord , 21 (7) pp. 1036-1039. 10.1002/mds.20864.

Frezza, C; Cipolat, S; Martins de Brito, O; Micaroni, M; Beznoussenko, GV; Rudka, T; Bartoli, D; (2006) OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion. Cell , 126 (1) pp. 177-189. 10.1016/j.cell.2006.06.025.

Fung, HC; Chen, CM; Hardy, J; Hernandez, D; Singleton, A; Wu, YR; (2006) Lack of G2019S LRRK2 mutation in a cohort of Taiwanese with sporadic Parkinson's disease. MOVEMENT DISORD , 21 (6) 880 - 881. 10.1002/mds.20814.

Fung, HC; Chen, CM; Hardy, J; Singleton, AB; Lee-Chen, GJ; Wu, YR; (2006) Analysis of the PINK1 gene in a cohort of patients with sporadic early-onset parkinsonism in Taiwan. NEUROSCI LETT , 394 (1) 33 - 36. 10.1016/j.neulet.2005.10.005.

Fung, HC; Chen, CM; Hardy, J; Singleton, AB; Wu, YR; (2006) A common genetic factor for Parkinson disease in ethnic Chinese population in Taiwan. BMC Neurology , 6 , Article 47. 10.1186/1471-2377-6-47. Green open access

Fung, HC; Scholz, S; Matarin, M; Simon-Sanchez, J; Hernandez, D; Britton, A; Gibbs, JR; (2006) Genome-wide genotyping in Parkinson's disease and neurologically normal controls: first stage analysis and public release of data. LANCET NEUROL , 5 (11) 911 - 916. 10.1016/S1474-4422(06)70578-6.

Fung, HC; Xiromerisiou, G; Gibbs, JR; Wu, YR; Eerola, J; Gourbali, V; Hellstrom, O; (2006) Association of tau haplotype-tagging polymorphisms with Parkinson's disease in diverse ethnic Parkinson's disease cohorts. NEURODEGENER DIS , 3 (6) 327 - 333. 10.1159/000097301.


Gandhi, S; Muqit, MMK; Abou-Sleiman, PM; Stanyer, L; Hargreaves, I; Heales, S; Ganguly, M; (2006) PINK1: a novel mitochondrial protein in Parkinson's disease. In: NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. (pp. 221 - 222). BLACKWELL PUBLISHING

Gandhi, S; Muqit, MMK; Stanyer, L; Healy, DG; Abou-Sleiman, PM; Hargreaves, I; Heales, S; (2006) PINK1 protein in normal human brain and Parkinson's disease. BRAIN , 129 1720 - 1731. 10.1093/brain/awl114.

Gandhi, S; Wood-Kaczmar, A; Jat, P; Latchman, DS; Tabrizi, SJ; Wood, NW; (2006) Investigation of PINK1 dysfunction in Parkinson's disease. In: MOVEMENT DISORDERS. (pp. S546 - S547). WILEY-LISS

Garcia, ML; Singleton, AB; Hernandez, D; Ward, CM; Evey, C; Sapp, PA; Hardy, J; (2006) Mutations in neurofilament genes are not a significant primary cause of non-SOD1-mediated amyotrophic lateral sclerosis. Neurobiol Dis , 21 (1) pp. 102-109. 10.1016/j.nbd.2005.06.016.

Geser, F; Wenning, GK; Sepp, K; Stampfer-Kountchev, M; Scherfler, C; Sawires, M; Frick, C; (2006) Progression of multiple system atrophy (MSA): A prospective natural history study by the European MSA Study Group (EMSA SG). MOVEMENT DISORD , 21 (2) 179 - 186. 10.1002/mds.20678.

Geser, F; Wenning, GK; Seppi, K; Stampfer-Kountchev, M; Scherfler, C; Sawires, M; Frick, C; (2006) Progression of multiple system atrophy (MSA): A prospective natural history study by the European MSA study group (EMSA SG). Movement Disorders , 21 (2) pp. 179-186. 10.1002/mds.20678.

Ghiso, J; Rostagno, A; Tomidokoro, Y; Lashley, T; Bojsen-Moller, M; Braendgaard, H; Plant, G; (2006) Genetic alterations of the BRI2 gene: Familial British and Danish dementias. BRAIN PATHOL , 16 (1) 71 - 79.

Gioltzoglou, T; Milonas, I; Lees, AJ; (2006) Case of DYT1 dystonia triggered by bite from a moray. MOVEMENT DISORD , 21 (9) 1536 - 1537. 10.1002/mds.20994.

Giunti, P; Stephenson, DA; Johnson, J; Abu-sleiman, P; Davis, MB; Houlden, H; Worth, PF; (2006) Linkage analysis on the SCA11 locus. In: MOVEMENT DISORDERS. (pp. S336 - S336). WILEY-LISS

Graves, TD; Schorge, S; Davies, RA; Wood, NW; Kullmann, DM; Hanna, MG; (2006) The role of the brain P/Q-type calcium channel in human epilepsy. EUR J NEUROL , 13 313 - 313.

Greenfield, J; Treacy, C; Giunti, P; (2006) Centres of Excellence for the care of people with progressive ataxias. Br J Nurs , 15 (17) pp. 932-936. 10.12968/bjon.2006.15.17.21908.

Greggio, E; Jain, S; Kingsbury, A; Bandopadhyay, R; Lewis, P; Kaganovich, A; van der Brug, MP; (2006) Kinase activity is required for the toxic effects of mutant LRRK2/dardarin. NEUROBIOL DIS , 23 (2) 329 - 341. 10.1016/j.nbd.2006.04.001.

Grosset, K; Morgan, FG; Main, MJ; Lees, AJ; Grosset, D; (2006) Oral inhalation of apomorphine provides rapid rescue from 'off' periods in Parkinson's disease (PD): a phase 2a clinical study. In: (pp. S645-S645).

Grupe, A; Li, YH; Rowland, C; Nowotny, P; Hinrichs, AL; Smemo, S; Kauwe, JSK; (2006) A scan of chromosome 10 identifies a novel locus showing strong association with late-onset Alzheimer disease. AMERICAN JOURNAL OF HUMAN GENETICS , 78 (1) pp. 78-88. 10.1086/498851.

Guerreiro, RJ; Bras, JM; Santana, I; Januario, C; Santiago, B; Morgadinho, AS; Ribeiro, MH; (2006) Association of HFE common mutations with Parkinson's disease, Alzheimer's disease and mild cognitive impairment in a Portuguese cohort. BMC Neurology , 6 , Article 24. 10.1186/1471-2377-6-24. Green open access

Gustincich, S; Sandelin, A; Plessy, C; Katayama, S; Simone, R; Lazarevic, D; Hayashizaki, Y; (2006) The complexity of the mammalian transcriptome. The Journal of Physiology , 575 (2) pp. 321-332. 10.1113/jphysiol.2006.115568.


Hallegger, M; Taschner, A; Jantsch, MF; (2006) RNA aptamers binding the double-stranded RNA-binding domain. RNA , 12 pp. 1993-2004. 10.1261/rna.125506.

Hanna, MG; (2006) Genetic neurological channelopathies. NAT CLIN PRACT NEURO , 2 (5) 252 - 263. 10.1038/ncpneuro0178.

Hansson, O; Zetterberg, H; Buchhave, P; Londos, E; Blennow, K; Minthon, L; (2006) Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study. Lancet Neurol , 5 (3) pp. 228-234. 10.1016/S1474-4422(06)70355-6.

Hansson, O; Zetterberg, H; Buchlave, P; Londos, E; Blennow, K; Minthon, L; (2006) Erratum: Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: A follow-up study (Lancet Neurology (2006) 5 (228-34)). Lancet Neurology , 5 (4) 293-. 10.1007/s11225-006-7204-0.

Hardy, J; (2006) Amyloid double trouble. Nat Genet , 38 (1) pp. 11-12. 10.1038/ng0106-11.

Hardy, J; (2006) Bad luck: an unappreciated limitation in the interpretation of twin studies. Am J Med Genet B Neuropsychiatr Genet , 141B (6) 681-. 10.1002/ajmg.b.30353.

Hardy, J; (2006) No definitive evidence for a role for the environment in the etiology of Parkinson's disease. Mov Disord , 21 (10) pp. 1790-1791. 10.1002/mds.21067.

Hardy, J; (2006) Progress in deciding a therapeutic approach to PSP. In: MOVEMENT DISORDERS. (pp. 437 - 438). WILEY-LISS

Hardy, J; (2006) A hundred years of Alzheimer's disease research. NEURON , 52 (1) 3 - 13. 10.1016/j.neuron.2006.09.016.

Hardy, J; Cai, H; Cookson, MR; Gwinn-Hardy, K; Singleton, A; (2006) Genetics of Parkinson's disease and parkinsonism. Ann Neurol , 60 (4) pp. 389-398. 10.1002/ana.21022.

Hardy, J; Cullen, K; (2006) Amyloid at the blood vessel wall. Nat Med , 12 (7) pp. 756-757. 10.1038/nm0706-756.

Hardy, J; Momeni, P; Traynor, BJ; (2006) Frontal temporal dementia: dissecting the aetiology and pathogenesis. Brain , 129 (Pt 4) pp. 830-831. 10.1093/brain/awl035.

Hardy, J; Orr, H; (2006) The genetics of neurodegenerative diseases. J NEUROCHEM , 97 (6) 1690 - 1699. 10.1111/j.1471-4159.2006.03979.x.

Hardy, J; Pittman, A; Myers, A; Fung, HC; de Silva, R; Duckworth, J; (2006) Tangle diseases and the tau haplotypes. ALZ DIS ASSOC DIS , 20 (1) 60 - 62.

Hardy, J; Scholz, S; Evans, W; Goldfarb, L; Singleton, A; (2006) Prion genotypes in Central America suggest selection for the V129 allele. Am J Med Genet B Neuropsychiatr Genet , 141B (1) pp. 33-35. 10.1002/ajmg.b.30248.

Healy, D; Muqit, M; Abu Sleiman, P; Yang, Y; Holton, J; Revesz, T; Quinn, N; (2006) A novel 5'UTR mutation of Nurr1 reduces Nurr1 expression in Parkinson's disease brain in vivo. In: MOVEMENT DISORDERS. (pp. S401 - S402). WILEY-LISS

Healy, DG; Abou-Sleiman, PM; Ahmadi, KR; Gandhi, S; Muqit, MM; Bhatia, KP; Quinn, NP; (2006) NR4A2 genetic variation in sporadic Parkinson's disease: A genewide approach. MOVEMENT DISORD , 21 (11) 1960 - 1963. 10.1002/mds.21018.

Healy, DG; Abou-Sleiman, PM; Ahmadi, KR; Gandhi, S; Muqit, MM; Bhatia, KP; Quinn, NP; (2006) NR4A2 genetic variation in sporadic Parkinson's disease: a genewide approach. Mov Disord , 21 (11) pp. 1960-3.

Healy, DG; Abou-Sleiman, PM; Casas, JP; Ahmadi, KR; Lynch, T; Gandhi, S; Muqit, MMK; (2006) UCHL-1 is not a Parkinson's disease susceptibility gene. ANN NEUROL , 59 (4) 627 - 633. 10.1002/ana.20757.

Henley, SMD; Frost, C; MacManus, DG; Warner, TT; Fox, NC; Tabrizi, SJ; (2006) Increased rate of whole-brain atrophy over 6 months in early Huntington disease. NEUROLOGY , 67 (4) 694 - 696.

Holton, JL; Beesley, C; Jackson, M; Venner, K; Bhardwaj, N; Winchester, B; Al-Memar, A; (2006) Autophagic vacuolar myopathy in twin girls. NEUROPATH APPL NEURO , 32 (3) 253 - 259.

Horstink, M; Tolosa, E; Bonuccelli, U; Deuschl, G; Friedman, A; Kanovsky, P; Larsen, JP; (2006) Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies (EFNS) and the Movement Disorder Society-European Section (MDS-ES). Part II: late (complicated) Parkinson's disease. Eur J Neurol , 13 (11) pp. 1186-1202. 10.1111/j.1468-1331.2006.01548.x.

Horstink, M; Tolosa, E; Bonuccelli, U; Deuschl, G; Friedman, A; Kanovsky, P; Larsen, JP; (2006) Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies and the Movement Disorder Society-European Section. Part I: early (uncomplicated) Parkinson's disease. Eur J Neurol , 13 (11) pp. 1170-1185. 10.1111/j.1468-1331.2006.01547.x.

Horvath, R; Hudson, G; Ferrari, G; Futterer, N; Ahola, S; Lamantea, E; Prokisch, H; (2006) Phenotypic spectrum associated with mutations of the mitochondrial polymerase gamma gene. BRAIN , 129 1674 - 1684. 10.1093/brain/awl088.

Houlden, H; Edwards, M; McNeil, J; Greenwood, R; (2006) Use of the Barthel Index and the Functional Independence Measure during early inpatient rehabilitation after single incident brain injury. CLIN REHABIL , 20 (2) 153 - 159. 10.1191/0269215506cr917oa.

Houlden, H; Greenwood, R; (2006) Apolipoprotein E4 and traumatic brain injury. J NEUROL NEUROSUR PS , 77 (10) 1106 - 1107. 10.1136/jnnp.2006.095513.

Houlden, H; King, R; Blake, J; Groves, M; Love, S; Woodward, C; Hammans, S; (2006) Clinical, pathological and genetic characterization of hereditary sensory and autonomic neuropathy type 1 (HSAN I). BRAIN , 129 411 - 425. 10.1093/brain/awh712.

Houlden, H; Reilly, MM; (2006) Molecular genetics of autosomal-dominant demyelinating Charcot-Marie-Tooth disease. NEUROMOL MED , 8 (1-2) 43 - 62. 10.1385/NMM:8:1-2:43.

Houlden, H; Reilly, MM; (2006) Molecular genetics of autosomal-dominant demyelinating Charcot-Marie-Tooth disease. Neuromolecular Med , 8 (1-2) pp. 43-62. 10.1385/NMM:8:1:243.

Hu, MTM; Scherfle, C; Khan, NL; Hajnal, JV; Lees, AJ; Quinn, N; Wood, NW; (2006) Nigral degeneration and striatal dopaminergic dysfunction in idiopathic and Parkin-linked Parkinson's disease. MOVEMENT DISORD , 21 (3) 299 - 305. 10.1002/mds.20702.

Hudson, G; Deschauer, M; Taylor, RW; Hanna, MG; Fialho, D; Schaefer, AM; He, LP; (2006) POLG1, C10ORF2, and ANT1 mutations are uncommon in sporadic progressive external ophthalmoplegia with multiple mitochondrial DNA deletions. NEUROLOGY , 66 (9) 1439 - 1441.

Huey, ED; Grafman, J; Wassermann, EM; Pietrini, P; Tierney, MC; Ghetti, B; Spina, S; (2006) Characteristics of frontotemporal dementia patients with a Progranulin mutation. Ann Neurol , 60 (3) pp. 374-380. 10.1002/ana.20969.

Hébert, SS; Serneels, L; Tolia, A; Craessaerts, K; Derks, C; Filippov, MA; Müller, U; (2006) Regulated intramembrane proteolysis of amyloid precursor protein and regulation of expression of putative target genes. EMBO Rep , 7 (7) pp. 739-745. 10.1038/sj.embor.7400704.


Ingelsson, M; Ramasamy, K; Cantuti-Castelvetri, I; Skoglund, L; Matsui, T; Orne, J; Kowa, H; (2006) No alteration in tau exon 10 alternative splicing in tangle-bearing neurons of the Alzheimer's disease brain. ACTA NEUROPATHOL , 112 (4) 439 - 449. 10.1007/s00401-006-0095-3.

Irani, SR; Holton, JL; Plant, GT; (2006) The ophthalmodesmoses: The occular manifestations of the distal arthrogryposes. In: (pp. p. 132).

Iseki, E; Yamamoto, R; Murayama, N; Minegishi, M; Togo, T; Katsuse, O; Kosaka, K; (2006) Immunohistochemical investigation of neurofibrillary tangles and their tau isoforms in brains of limbic neurofibrillary tangle dementia. Neurosci Lett , 405 (1-2) pp. 29-33. 10.1016/j.neulet.2006.06.036.


Kamphuis, DJ; Koelman, H; Lees, AJ; Tijssen, MA; (2006) Sporadic rapid-onset dystonia-parkinsonism presenting as Parkinson's disease. Mov Disord , 21 (1) pp. 118-9.

Kamphuis, DJ; Koelman, H; Lees, AJ; Tijssen, MAJ; (2006) Sporadic rapid-onset dystonia-parkinsonism presenting as Parkinson's disease. MOVEMENT DISORD , 21 (1) 118 - 119. 10.1002/mds.20695.

Katzenschlager, R; Jackson, MJ; Rose, S; Stockwell, K; Tayarani-Binazir, KA; Zubair, M; Smith, LA; (2006) The antiparkinsonian activity of L-Propyl-L-Leucyl-Glycinamide (PLG) or Melanocyte-Inhibiting Factor (MIF) in MPTP-treated common marmosets. In: (pp. S461-S461).

Khan, N.L.; (2006) Familial parkinsonism [Parkinson's disease and early onset parkinsonism]: a genetic, clinical study and 18F-dopa pet study. Doctoral thesis, University of London. Green open access

Kinghorn, KJ; Crowther, DC; Sharp, LK; Nerelius, C; Davis, RL; Chang, HT; Green, C; (2006) Neuroserpin binds Abeta and is a neuroprotective component of amyloid plaques in Alzheimer disease. J Biol Chem , 281 (39) pp. 29268-29277. 10.1074/jbc.M600690200. Gold open access

Kingsbury, A; Bandopadhyay, R; Lees, A; (2006) DJ-1 (PARK7) mRNA expression in human brain. In: NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. (pp. 234 - 234). BLACKWELL PUBLISHING

Kinirons, P; Cavalleri, GL; Shahwan, A; Wood, NW; Goldstein, DB; Sisodiya, SM; Delanty, N; (2006) Examining the role of common genetic variation in the gamma 2 subunit of the GABA(A) receptor in epilepsy using tagging SNPs. EPILEPSY RES , 70 (2-3) 229 - 238. 10.1016/j.eplepsyres.2005.05.009.

Kinirons, P; Cavalleri, GL; Shahwan, A; Wood, NW; Goldstein, DB; Sisodiya, SM; Delanty, N; (2006) Examining the role of common genetic variation in the gamma2 subunit of the GABA(A) receptor in epilepsy using tagging SNPs. Epilepsy Res , 70 (2-3) pp. 229-238. 10.1016/j.eplepsyres.2006.05.009.

Kinirons, P; Cavalleri, GL; Singh, R; Shahwan, A; Acheson, JF; Wood, NW; Goldstein, DB; (2006) A pharmacogenetic exploration of vigabatrin-induced visual field constriction. EPILEPSY RES , 70 (2-3) 144 - 152. 10.1016/j.eplepsyres.2006.03.012.

Kohoutová, M; Stekrová, J; Sulová, M; Zidková, K; Kleibl, Z; Vandrovcová, J; Kebrdlová, V; (2006) [Hereditary forms of colorectal adenomatous polyposis]. Cas Lek Cesk , 145 (6) pp. 475-479.

Kumaran, R; Bandopadhyay, R; Lees, AJ; (2006) Biochemical properties of DJ-1 (PARK 7) in human brain tissue. In: MOVEMENT DISORDERS. (pp. S347 - S348). WILEY-LISS


Lashley, T; Holton, JL; Verbeek, MM; Rostagno, A; Bojsen-Moller, M; David, G; van Horssen, J; (2006) Molecular chaperons, amyloid and preamyloid lesions in the BRI2 gene-related dementias: a morphological study. NEUROPATH APPL NEURO , 32 (5) 492 - 504. 10.1111/j.1365-2990.2006.00747.x.

Lashley, T.; (2006) Bri1 gene-related dementias; A morphological and biochemical study. Doctoral thesis, University of London. Green open access

Lees, A; (2006) Response from the editors. MOVEMENT DISORDERS , 21 (3) p. 433.

Lees, AJ; (2006) What is Parkinson's disease? In: (pp. S30-S31).

Li, Y; Grupe, A; Rowland, C; Nowotny, P; Kauwe, JSK; Smemo, S; Hinrichs, A; (2006) DAPK1 variants are associated with Alzheimer's disease and allele-specific expression. HUMAN MOLECULAR GENETICS , 15 (17) pp. 2560-2568. 10.1093/hmg/ddl178.

Luk, CY; Giovannoni, G; Lees, AJ; de Silva, R; (2006) Development of an ELISA for sensitive quantification of three-repeat and four-repeat tau isoforms in tauopathies and characterisation of tau isoforms in CSF. In: MOVEMENT DISORDERS. (pp. S345 - S345). WILEY-LISS

Lymperopoulos, K; Noad, R; Tosi, S; Nethisinghe, S; Brierley, I; Roy, P; (2006) Specific binding of Bluetongue virus NS2 to different viral plus-strand RNAs. VIROLOGY , 353 (1) 17 - 26. 10.1016/j.virol.2006.04.022.

Lynch, JM; Tate, SK; Sander, J; Wood, NW; Goldstein, DB; Sisodiya, SM; (2006) A novel method to characterise the phenotype of levetiracetam response for genetic association studies. In: NEUROLOGY. (pp. A132 - A133). LIPPINCOTT WILLIAMS & WILKINS


Malkani, R; D'Souza, I; Gwinn-Hardy, K; Schellenberg, GD; Hardy, J; Momeni, P; (2006) A MAPT mutation in a regulatory element upstream of exon 10 causes frontotemporal dementia. Neurobiol Dis , 22 (2) pp. 401-403. 10.1016/j.nbd.2005.12.001.

Marchionni, I; Paffi, A; Pellegrino, M; Liberti, M; Apollonio, F; Abeti, R; Fontana, F; (2006) Comparison between low-level 50 Hz and 900 MHz electromagnetic stimulation on single channel ionic currents and on firing frequency in dorsal root ganglion isolated neurons. Biochim Biophys Acta , 1758 (5) pp. 597-605. 10.1016/j.bbamem.2006.03.014.

Marlowe, L; Peila, R; Benke, KS; Hardy, J; White, LR; Launer, LJ; Myers, A; (2006) Insulin-degrading enzyme haplotypes affect insulin levels but not dementia risk. Neurodegener Dis , 3 (6) pp. 320-326. 10.1159/000097300.

Masellis, M; Momeni, P; Meschino, W; Heffner, R; Elder, J; Sato, C; Liang, Y; (2006) Novel splicing mutation in the progranulin gene causing familial corticobasal syndrome. Brain , 129 (Pt 11) pp. 3115-3123. 10.1093/brain/awl276.

Matarin, MM; Singleton, AB; Houlden, H; (2006) PANK2 gene analysis confirms genetic heterogeneity in neurodegeneration with brain iron accumulation (NBIA) but mutations are rare in other types of adult neurodegenerative disease. NEUROSCI LETT , 407 (2) 162 - 165. 10.1016/j.neulet.2006.08.030.

Mayahi, L; Mason, L; Storry, C; Donald, A; Trender-Gherhard, I; Mathias, C; Deanfield, J; (2006) Endothelial, sympathetic and cardiac function in inherited 6R-L-Erythro-5,6,7,8-Tetrahydro-L-Biopterin deficiency. CIRCULATION , 114 (18) 283 - 283.

Merikangas, KR; Low, NCP; Hardy, J; (2006) Commentary: understanding sources of complexity in chronic diseases--the importance of integration of genetics and epidemiology. Int J Epidemiol , 35 (3) pp. 590-592. 10.1093/ije/dyl007.

Momeni, P; Bell, J; Duckworth, J; Hutton, M; Mann, D; Brown, SP; Hardy, J; (2006) Sequence analysis of all identified open reading frames on the frontal temporal dementia haplotype on chromosome 3 fails to identify unique coding variants except in CHMP2B. Neurosci Lett , 410 (2) pp. 77-79. 10.1016/j.neulet.2006.06.065.

Momeni, P; Rogaeva, E; Van Deerlin, V; Yuan, W; Grafman, J; Tierney, M; Huey, E; (2006) Genetic variability in CHMP2B and frontotemporal dementia. Neurodegener Dis , 3 (3) pp. 129-133. 10.1159/000094771.

Momeni, P; Schymick, J; Jain, S; Cookson, MR; Cairns, NJ; Greggio, E; Greenway, MJ; (2006) Analysis of IFT74 as a candidate gene for chromosome 9p-linked ALS-FTD. BMC Neurol , 6 44-. 10.1186/1471-2377-6-44. Gold open access

Muqit, MM; Gandhi, S; Deas, E; Abou-Sleiman, PM; Harvey, K; Harvey, RJ; Wood, NW; (2006) A site-directed mutagenesis study of putative cleavage sites of the Parkinson's disease associated gene, PINK1. In: MOVEMENT DISORDERS. (pp. S560 - S560). WILEY-LISS

Muqit, MMK; Abou-Sleiman, PM; Saurin, AT; Harvey, K; Gandhi, S; Deas, E; Eaton, S; (2006) Altered cleavage and localization of PINK1 to aggresomes in the presence of proteasomal stress. J NEUROCHEM , 98 (1) 156 - 169. 10.1111/j.1471-4159.2006.03845.x.

Muqit, MMK; Gandhi, S; Wood, NW; (2006) Mitochondria in Parkinson disease - Back in fashion with a little help from genetics. ARCH NEUROL-CHICAGO , 63 (5) 649 - 654.

Murphy, S; McNamara, B; (2006) How well is peripheral neuropathy investigated? An audit from a regional neurophysiology department. Irish Journal of Medical Science , 175 (1) pp. 54-56.

Muthane, UB; Chickabasaviah, YT; Henderson, J; Kingsbury, AE; Kilford, L; Shankar, SK; Subbakrishna, DK; (2006) Melanized nigral neuronal numbers in Nigerian and British individuals. Mov Disord , 21 (8) pp. 1239-1241. 10.1002/mds.20917.


Nirmalananthan, N; Hanna, MG; (2006) Predicting steroid response in muscle disease. J NEUROL NEUROSUR PS , 77 (10) 1104 - 1105. 10.1136/jnnp.2006.087874.


Otaegui, D; Sáenz, A; Camaño, P; Blázquez, L; Goicoechea, M; Ruíz-Martínez, J; Olaskoaga, J; (2006) CD24 V/V is an allele associated with the risk of developing multiple sclerosis in the Spanish population. Multiple Sclerosis Journal , 12 (4) pp. 511-514. 10.1191/135248506ms1314sr.

Ozawa, T; Healy, DG; Abou-Sleiman, PM; Ahmadi, KR; Quinn, N; Lees, AJ; Shaw, K; (2006) The alpha-synuclein gene in multiple system atrophy. J NEUROL NEUROSUR PS , 77 (4) 464 - 467. 10.1136/jnnp.2005.073528.

Ozawa, T; Healy, DG; Quinn, NP; Bozi, M; Paviour, D; Josephs, KA; Lees, AJ; (2006) Clinicopathological features of patients with multiple system atrophy with a family history of Parkinson's disease. In: MOVEMENT DISORDERS. (pp. S527 - S527). WILEY-LISS


Paisan-Ruiz, C; Evans, EW; Jain, S; Xiromerisiou, G; Gibbs, JR; Eerola, J; Gourbali, V; (2006) Testing association between LRRK2 and Parkinson's disease and investigating linkage disequilibrium. J MED GENET , 43 (2) , Article e9. 10.1136/jmg.2005.036889.

Patani, R; Lunn, MP; Groves, M; Reilly, MM; (2006) Paraneoplastic CIDP associated with transitional cell carcinoma: A case report and review of the literature. In: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. (pp. 1401 - 1401). B M J PUBLISHING GROUP

Pavese, N; Evans, AH; Tai, YF; Hotton, G; Brooks, DJ; Lees, AJ; Piccini, P; (2006) Clinical correlates of levodopa-induced dopamine release in Parkinson disease - A PET study. NEUROLOGY , 67 (9) pp. 1612-1617. 10.1212/01.wnl.0000242888.30755.5d.

Pavese, N; Khan, NL; Scherfler, C; Cohen, L; Wood, NW; Quinn, NA; Lees, AJ; (2006) Nigrostriatal dysfunction in parkin-linked parkinsonism and asymptornatic heterozygous carriers. A progression study with F-18-dopa PET. In: (pp. S536-S536).

Pavese, N; Scherfler, C; Khan, NL; Moore, RY; Hotton, G; Lees, AJ; Quinn, NP; (2006) Brain monoaminergic innervation in Parkin patients: A PET study. In: (pp. A134-A134).

Pavese, N; Scherfler, C; Khan, NL; Moore, RY; Hotton, G; Lees, AJ; Quinn, NP; (2006) Brain monoamineric innervation in parkin patients: A PET study. In: (pp. A332-A332).

Paviour, D; Price, SL; Lees, AJ; Fox, NC; (2006) MRI derived brain atrophy rates in PSP and MSA-P: clinical correlations and sample sizes. In: (pp. S633-S634).

Paviour, D; Price, SL; Lees, AJ; Fox, NC; (2006) Phenotypic variability in PSP: Unbiased analysis of serial MRI. In: (pp. S622-S622).

Paviour, D; Thornton, JS; Lees, AJ; Jager, R; (2006) Diffusion weighted MRI differentiates MSA-P from PSP. In: (pp. S633-S633).

Paviour, DC; Jager, HR; Wilkinson, L; Jahanshahi, M; Lees, AJ; (2006) Holmes tremor: Application of modern neuroimaging techniques. MOVEMENT DISORD , 21 (12) 2260 - 2262. 10.1002/mds.20981.

Paviour, DC; Price, SL; Jahanshahi, M; Lees, AJ; Fox, NC; (2006) Longitudinal MRI in progressive supranuclear palsy and multiple system atrophy: rates and regions of atrophy. BRAIN , 129 1040 - 1049. 10.1093/brain/awl021.

Paviour, DC; Price, SL; Jahanshahi, M; Lees, AJ; Fox, NC; (2006) Regional brain volumes distinguish PSP, MSA-P, and PD: MRI-based clinico-radiological correlations. MOVEMENT DISORD , 21 (7) 989 - 996. 10.1002/mds.20877.

Perez-Lloret, S; Lopez, M; Rossi, A; Merello, M; Lees, AJ; (2006) Lack of efficacy of one serving of coca tea as add-on therapy to a single levodopa dose in Parkinson's disease patients: A pilot study. In: (pp. S636-S636).

Pineda-Trujillo, N; Apergi, M; Moreno, S; Arias, W; Lesage, S; Franco, A; Sepulveda-Falla, D; (2006) A genetic cluster of early onset Parkinson's disease in a Colombian population. AM J MED GENET B , 141B (8) 885 - 889. 10.1002/ajmg.b.30375.

Pittman, A; Myers, A; Hardy, J; Wood, N; Lees, AJ; de Silva, R; (2006) Increased MAPT expression as the possible functional basis of the genetic association with PSP. In: MOVEMENT DISORDERS. (pp. S415 - S415). WILEY-LISS

Pittman, AM; Fung, HC; de Silva, R; (2006) Untangling the tau gene association with neurodegenerative disorders. HUM MOL GENET , 15 R188 - R195. 10.1093/hmg/ddl190.

Portelius, E; Westman-Brinkmalm, A; Zetterberg, H; Blennow, K; (2006) Determination of beta-amyloid peptide signatures in cerebrospinal fluid using immunoprecipitation-mass spectrometry. J Proteome Res , 5 (4) pp. 1010-1016. 10.1021/pr050475v.

Portelius, E; Zetterberg, H; Andreasson, U; Brinkmalm, G; Andreasen, N; Wallin, A; Westman-Brinkmalm, A; (2006) An Alzheimer's disease-specific beta-amyloid fragment signature in cerebrospinal fluid. Neurosci Lett , 409 (3) pp. 215-219. 10.1016/j.neulet.2006.09.044.


Rascol, O; Dubois, B; Caldas, AC; Senn, S; Del Signore, S; Lees, A; Parkinson REGAIN Study Grp, ; (2006) Early piribedil monotherapy of Parkinson's disease: A planned seven-month report of the REGAIN study. MOVEMENT DISORD , 21 (12) 2110 - 2115. 10.1002/mds.21122.

Rascol, O; Lees, AJ; Poewe, W; Salin, L; ADVANS, ; (2006) NS 2330, a DA reuptake inhibitor, in levodopa-treated patients with Parkinson's disease and motor fluctuations: The Phase II ADVANS study. In: (pp. S515-S515).

Rees, JH; Weil, RS; Waldman, AD; Jager, HR; Benton, CE; Tozer, DJ; Altman, DR; (2006) Gadolinium enhancement index predicts transformation in adult low-grade gliomas. EUR J NEUROL , 13 280 - 280.

Revesz, T; Holton, J; (2006) Lewy body formation and deposition of amyloid-beta: Overlapping or synergistic pathologies? In: JOURNAL OF THE NEUROLOGICAL SCIENCES. (pp. 309 - 309). ELSEVIER SCIENCE BV

Rossi, S; Bartalini, S; Ulivelli, M; (2006) Antiparkinsonian drugs and visual hallucinations. Lancet Neurol , 5 (1) pp. 18-19. 10.1016/S1474-4422(05)70267-2.


Scherfler, C; Khan, NL; Pavese, N; Lees, AJ; Quinn, NP; Brooks, DJ; Piccini, PP; (2006) Upregulation of dopamine D-2 receptors in dopaminergic drug-naive patients with Parkin gene mutations. MOVEMENT DISORD , 21 (6) 783 - 788. 10.1002/mds.20811.

Schmitt, I; Wullner, U; Healy, DG; Wood, NW; Kolsch, H; Henn, R; (2006) The ADH1C stop mutation in multiple system atrophy patients and healthy probands in the United Kingdom and Germany. MOVEMENT DISORD , 21 (11) 2034 - 2034. 10.1002/mds.21082.

Schmitz-Hubsch, T; du Montcel, ST; Baliko, L; Berciano, J; Boesch, S; Depondt, C; Giunti, P; (2006) Scale for the assessment and rating of ataxia - Development of a new clinical scale. NEUROLOGY , 66 (11) 1717 - 1720. 10.1212/01.wnl.0000219042.60538.92.

Schmitz-Hubsch, T; du Montcel, ST; Baliko, L; Boesch, S; Bonato, S; Fancellu, R; Giunti, P; (2006) Reliability and validity of the International Cooperative Ataxia Rating Scale: A study in 156 spinocerebellar ataxia patients. MOVEMENT DISORD , 21 (5) 699 - 704. 10.1002/mds.20781.

Schneider, SA; Mohire, MD; Trender-Gerhard, I; Asmus, F; Sweeney, M; Davis, M; Gasser, T; (2006) Familial dopa-responsive cervical dystonia. NEUROLOGY , 66 (4) 599 - 601.

Schneider, SA; Mohire, MD; Trender-Gerhard, I; Asmus, F; Sweeney, M; Mary, D; Gasser, T; (2006) Familial dopa-responsive cervical dominant dystonia. In: MOVEMENT DISORDERS. (pp. S395 - S395). WILEY-LISS

Schneider, SA; van de Warrenburg, BPC; Hughes, TD; Davis, M; Sweeney, M; Wood, N; Quinn, NP; (2006) Phenotypic homogeneity of the Huntington disease - like presentation in a SCA17 family. NEUROLOGY , 67 (9) 1701 - 1703.

Schott, JM; Williams, DR; Butterworth, R; Janssen, JC; Larner, AJ; Holton, JL; Rossor, MN; (2006) Shunt responsive progressive supranuclear palsy. In: MOVEMENT DISORDERS. (pp. S524 - S524). WILEY-LISS

Schrag, A; Geser, F; Stampfer-Kountchev, M; Seppi, K; Sawires, M; Kollensperger, M; Scherfler, C; (2006) Health-related quality of life in multiple system atrophy. MOVEMENT DISORD , 21 (6) 809 - 815. 10.1002/mds.20808.

Schrag, A; Geser, F; StampferKountchev, M; Seppi, K; Sawires, M; Köllensperger, M; Scherfler, C; (2006) Health-related quality of life in multiple system atrophy. Movement Disorders , 21 (6) pp. 809-815. 10.1002/mds.20808.

Schrag, A; Selai, C; Quinn, N; Lees, A; Litvan, I; Lang, A; Poon, Y; (2006) Measuring quality of life in PSP - The PSP-QoL. NEUROLOGY , 67 (1) 39 - 44.

Schrag, A.; Selai, C.; Quinn, N.; Lees, A.; Litvan, I.; Lang, A.; Poon, Y.; (2006) Measuring quality of life in PSP: the PSP-QoL. Neurology , 67 (1) pp. 39-44. 10.1212/01.wnl.0000223826.84080.97.

Seal, JL; Gornick, MC; Gogtay, N; Shaw, P; Greenstein, DK; Coffey, M; Gochman, PA; (2006) Segmental uniparental isodisomy on 5q32-qter in a patient with childhood-onset schizophrenia. J Med Genet , 43 (11) pp. 887-892. 10.1136/jmg.2006.043380.

Sharma, M; Mueller, JC; Zimprich, A; Lichtner, P; Hofer, A; Leitner, P; Maass, S; (2006) The sepiapterin reductase gene region reveals association in the PARK3 locus: analysis of familial and sporadic Parkinson's disease in European populations. J MED GENET , 43 (7) 557 - 562. 10.1136/jmg.2005.039149.

Sharp, LK; Mallya, M; Kinghorn, KJ; Wang, Z; Crowther, DC; Huntington, JA; Belorgey, D; (2006) Sugar and alcohol molecules provide a therapeutic strategy for the serpinopathies that cause dementia and cirrhosis. FEBS J , 273 (11) pp. 2540-2552. 10.1111/j.1742-4658.2006.05262.x.

Shatunov, A; Sambuughin, N; Jankovic, J; Elble, R; Lee, HS; Singleton, AB; Dagvadorj, A; (2006) Genomewide scans in North American families reveal genetic linkage of essential tremor to a region on chromosome 6p23. Brain , 129 (Pt 9) pp. 2318-2331. 10.1093/brain/awl120.

Shaw-Smith, C; Pittman, A; Willatt, L; Martin, H; Rickman, L; Gribble, S; Rosenberg, C; (2006) Microdeletion encompassing the MAPT gene at chromosome 17q21.3 is associated with developmental delay and learning disability. In: JOURNAL OF MEDICAL GENETICS. (pp. S52 - S52). B M J PUBLISHING GROUP

Shaw-Smith, C; Pittman, AM; Willatt, L; Martin, H; Rickman, L; Gribble, S; Curley, R; (2006) Microdeletion encompassing MAPT at chromosome 17q21.3 is associated with developmental delay and learning disability. Nature Genetics , 38 (9) pp. 1032-1037. 10.1038/ng1858.

Shaw-Smith, C; Pittman, AM; Willatt, L; Martin, H; Rickman, L; Gribble, S; Curley, R; (2006) Microdeletion encompassing MAPT at chromosome 17q21.3 is associated with developmental delay and learning disability. NAT GENET , 38 (9) 1032 - 1037. 10.1038/ng1864.

Shaw-Smith, C; Pittman, AM; Willatt, L; Martin, H; Rickman, L; Gribble, S; Curley, R; (2006) Microdeletion encompassing MAPT at chromosome 17q21.3 is associated with developmental delay and learning disability. Nat Genet , 38 (9) pp. 1032-1037. 10.1038/ng1858.

Shaw-Smith, C.; Pittman, A.M.; Willatt, L.; Martin, H.; Rickman, L.; Gribble, S.; Curley, R.; (2006) Microdeletion encompassing MAPT at chromosome 17q21.3 is associated with developmental delay and learning disability. Nature Genetics , 38 (9) pp. 1032-1037. 10.1038/ng1858.

Silveira-Moriyama, L; Bandopadhyay, R; Kingsbury, AE; Lees, AJ; (2006) DJ-1 (PARK 7) immunoreactivity in the anterior olfactory nucleus and olfactory tract of Parkinson's disease, progressive supranuclear palsy and control cases. In: MOVEMENT DISORDERS. (pp. S343 - S343). WILEY-LISS

Silveira-Moriyama, L; Evans, AH; Katzenschlager, R; Lees, AJ; (2006) Punding and dyskinesias. MOVEMENT DISORD , 21 (12) 2214 - 2217. 10.1002/mds.21118.

Silveira-Moriyama, L; Williams, DR; Evans, AH; Katzenchlager, R; Watt, H; Lees, AJ; (2006) A UK comparison of Sniffin' Sticks (SS) and University of Pennsylvania (UPSIT) Smell Identification Tests in Parkinson's disease. In: MOVEMENT DISORDERS. (pp. S551 - S551). WILEY-LISS

Simon-Sanchez, J; Marti-Masso, JF; Sanchez-Mut, JV; Paisan-Ruiz, C; Martinez-Gil, A; Ruiz-Martinez, J; Saenz, A; (2006) Parkinson's disease due to the R1441G mutation in Dardarin: A founder effect in the Basques. MOVEMENT DISORD , 21 (11) 1954 - 1959. 10.1002/mds.21114.

Skoglund, J; Djureinovic, T; Zhou, XL; Vandrovcova, J; Renkonen, E; Iselius, L; Bisgaard, ML; (2006) Linkage analysis in a large Swedish family supports the presence of a susceptibility locus for adenoma and colorectal cancer on chromosome 9q22.32-31.1. J MED GENET , 43 (2) ? - ?. 10.1136/jmg.2005.033928.

Smemo, S; Nowotny, P; Hinrichs, AL; Kauwe, JSK; Cherny, S; Erickson, K; Myers, AJ; (2006) Ubiquilin 1 polymorphisms are not associated with late-onset Alzheimer's disease. ANNALS OF NEUROLOGY , 59 (1) pp. 21-26. 10.1002/ana.20673.

Soreq, L; (2006) Math1 target genes are enriched with evolutionarily conserved clustered E-box binding sites. Journal of Molecular Neuroscience , 28 (2) 10.1385/JMN:28:2:211.

Spasic, D; Tolia, A; Dillen, K; Baert, V; De Strooper, B; Vrijens, S; Annaert, W; (2006) Presenilin-1 maintains a nine-transmembrane topology throughout the secretory pathway. J Biol Chem , 281 (36) pp. 26569-26577. 10.1074/jbc.M600592200.

Stanyer, L; Jorgensen, W; Clark, JB; Heales, SJ; (2006) Oxidative inactivation of mitochondrial ion protease precedes electron transport chain (ETC) dysfunction. In: JOURNAL OF NEUROCHEMISTRY. (pp. 50 - 50). BLACKWELL PUBLISHING

Strand, C; Williams, D; De Silva, R; Holton, J; Revesz, T; (2006) Determining 3-repeat tau pathology in PSP. In: MOVEMENT DISORDERS. (pp. S525 - S525). WILEY-LISS


Thal, LJ; Kantarci, K; Reiman, EM; Klunk, WE; Weiner, MW; Zetterberg, H; Galasko, D; (2006) The role of biomarkers in clinical trials for Alzheimer disease. Alzheimer Dis Assoc Disord , 20 (1) pp. 6-15. 10.1097/01.wad.0000191420.61260.a8.

Theuns, J; Marjaux, E; Vandenbulcke, M; Van Laere, K; Kumar-Singh, S; Bormans, G; Brouwers, N; (2006) Alzheimer dementia caused by a novel mutation located in the APP C-terminal intracytosolic fragment. Hum Mutat , 27 (9) pp. 888-896. 10.1002/humu.20402.

Tofaris, GK; Garcia Reitböck, P; Humby, T; Lambourne, SL; O'Connell, M; Ghetti, B; Gossage, H; (2006) Pathological changes in dopaminergic nerve cells of the substantia nigra and olfactory bulb in mice transgenic for truncated human alpha-synuclein(1-120): implications for Lewy body disorders. J Neurosci , 26 (15) pp. 3942-3950. 10.1523/JNEUROSCI.4965-05.2006.

Tolia, A; Chávez-Gutiérrez, L; De Strooper, B; (2006) Contribution of presenilin transmembrane domains 6 and 7 to a water-containing cavity in the gamma-secretase complex. J Biol Chem , 281 (37) pp. 27633-27642. 10.1074/jbc.M604997200.

Tu, H; Nelson, O; Bezprozvanny, A; Wang, Z; Lee, S-F; Hao, Y-H; Serneels, L; (2006) Presenilins form ER Ca2+ leak channels, a function disrupted by familial Alzheimer's disease-linked mutations. Cell , 126 (5) pp. 981-993. 10.1016/j.cell.2006.06.059.


Ule, J; Darnell, RB; (2006) RNA binding proteins and the regulation of neuronal synaptic plasticity. Curr Opin Neurobiol , 16 (1) pp. 102-110. 10.1016/j.conb.2006.01.003.

Ule, J; Darnell, RB; (2006) RNA regulation and modular control of the neuronal synapse. International Journal of Developmental Neuroscience , 24 (8) p. 479. 10.1016/j.ijdevneu.2006.09.023.

Ule, J; Stefani, G; Mele, A; Ruggiu, M; Wang, X; Taneri, B; Gaasterland, T; (2006) An RNA map predicting Nova-dependent splicing regulation. Nature , 444 (7119) pp. 580-586. 10.1038/nature05304.


Valente, E; Brady, JD; McGregor, L; Soutar, M; Vazquez, M; Wilson, L; (2006) Performance evaluation of an automated microparticle enzyme immunoassay (MEIA) for holo-transcobalamin, AxSYM (R) HoloTC. In: CLINICAL CHEMISTRY. (pp. A179 - A179). AMER ASSOC CLINICAL CHEMISTRY

Vandrovcova, J; Lagerstedt-Robinsson, K; Pahlman, L; Lindblom, A; (2006) Somatic BRAF-V600E mutations in familial colorectal cancer. CANCER EPIDEM BIOMAR , 15 (11) 2270 - 2273. 10.1158/1055-9965.EPI-06-0359.

Varsani, H; Newton, KR; Li, CK; Holton, JL; Harding, B; Wedderburn, LR; (2006) Quantitative analysis of paediatric muscle biopsies reported as 'normal': Establishing a comparator cohort. In: ANNALS OF THE RHEUMATIC DISEASES. (pp. 574 - 574). B M J PUBLISHING GROUP

Venance, SL; Cannon, SC; Fialho, D; Fontaine, B; Hanna, MG; Ptacek, LJ; Tristani-Firouzi, M; (2006) The primary periodic paralyses: diagnosis, pathogenesis and treatment. BRAIN , 129 8 - 17. 10.1093/brain/awh639.

Vogt, IR; Lees, AJ; Evert, BO; Klockgether, T; Bonin, M; Wüllner, U; (2006) Transcriptional changes in multiple system atrophy and Parkinson's disease putamen. Exp Neurol , 199 (2) pp. 465-478. 10.1016/j.expneurol.2006.01.008.

van de Warrenburg, BP; Giunti, P; Schneider, SA; Quinn, NP; Wood, NW; Bhatia, KP; (2006) The syndrome of (predominantly cervical) dystonia and cerebellar ataxia: new cases indicate a distinct but heterogeneous entity. In: MOVEMENT DISORDERS. (pp. S338 - S339). WILEY-LISS


Warren, NM; Piggott, MA; Lees, AJ; Burn, DJ; (2006) Muscarinic receptors in the frontal cortex in progessive supranuclear plasy. In: (pp. S535-S536).

Wedderburn, LR; Varsani, H; Li, CK; Amato, AA; Banwell, B; Bove, KE; Corse, AM; (2006) A proposed score tool with which to define abnormalities on muscle biopsy from children with juvenile dermatomyositis. In: ARTHRITIS AND RHEUMATISM. (pp. S657 - S658). WILEY-LISS

Weil, RS; Cohen, JM; Portarena, I; Brada, M; (2006) Optimal dose of stereotactic radiosurgery for acoustic neuromas: a systematic review. BRITISH JOURNAL OF NEUROSURGERY , 20 (4) pp. 195-202. 10.1080/02688690600886108.

Weil, RS; Rees, JH; (2006) Epilepsy in patients with low-grade glioma in a tertiary referral centre. EUROPEAN JOURNAL OF NEUROLOGY , 13 p. 12.

Willem, M; Garratt, AN; Novak, B; Citron, M; Kaufmann, S; Rittger, A; DeStrooper, B; (2006) Control of peripheral nerve myelination by the beta-secretase BACE1. Science , 314 (5799) pp. 664-666. 10.1126/science.1132341.

Williams, DR; Lees, A; (2006) Antiparkinsonian drugs and visual hallucinations - Authors' response. LANCET NEUROL , 5 (1) 19 - 20.

Williams, DR; Revesz, T; Lees, AJ; (2006) Pure akinesia with gait freezing: A 3rd PSP phenotype. In: MOVEMENT DISORDERS. (pp. S537 - S537). WILEY-LISS

Williams, DR; Watt, HC; Lees, AJ; (2006) Predictors of falls and fractures in bradykinetic rigid syndromes: a retrospective study. J NEUROL NEUROSUR PS , 77 (4) 468 - 473. 10.1136/jnnp.2005.074070. Gold open access

Williams, DR; Watt, HC; Lees, AJ; (2006) Predictors of falls and fractures in bradykinetic rigid syndromes: a retrospective study. J Neurol Neurosurg Psychiatry. J Neurol Neurosurg Psychiatry , 77 (4) pp. 468-73.

Wood, N; Brewin, CR; McLeod, HJ; (2006) Autobiographical memory deficits in schizophrenia. COGNITION EMOTION , 20 (3-4) 536 - 547. 10.1080/02699930500342472.

Wood, NW; (2006) Pharmacogenetic approaches to neurological disease - Epilepsy as an example. EUR J NEUROL , 13 1 - 1.

Wood-Kaczmar, A; Gandhi, S; Jat, P; Miljan, EA; Sinden, J; Keen, GJ; Taylor, J; (2006) Generation of a cellular model of PINK1 parkinsonism in primary human dopaminergic neurons. In: MOVEMENT DISORDERS. (pp. S546 - S546). WILEY-LISS

Wood-Kaczmar, A; Gandhi, S; Wood, NW; (2006) Understanding the molecular causes of Parkinson's disease. TRENDS MOL MED , 12 (11) 521 - 528. 10.1016/j.molmed.2006.09.007.


Yokota, O; Tsuchiya, K; Oda, T; Ishihara, T; de Silva, R; Lees, AJ; Arai, T; (2006) Amyotrophic lateral sclerosis with dementia: an autopsy case showing many Bunina bodies, tau-positive neuronal and astrocytic plaque-like pathologies, and pallido-nigral degeneration. ACTA NEUROPATHOL , 112 (5) 633 - 645. 10.1007/s00401-006-0141-1.


Zetterberg, H; (2006) Re: "The inconsistency of 'optimal' cutpoints obtained using two criteria based on the receiver operating characteristic curve". Am J Epidemiol , 164 (7) pp. 707-708. 10.1093/aje/kwj292.

Zetterberg, H; Blennow, K; (2006) Plasma Abeta in Alzheimer's disease--up or down? Lancet Neurol , 5 (8) pp. 638-639. 10.1016/S1474-4422(06)70503-8.

Zetterberg, H; Campbell, WA; Yang, HW; Xia, W; (2006) The cytosolic loop of the gamma-secretase component presenilin enhancer 2 protects zebrafish embryos from apoptosis. J Biol Chem , 281 (17) pp. 11933-11939. 10.1074/jbc.M512521200.

Zetterberg, H; Hietala, MA; Jonsson, M; Andreasen, N; Styrud, E; Karlsson, I; Edman, A; (2006) Neurochemical aftermath of amateur boxing. Arch Neurol , 63 (9) pp. 1277-1280. 10.1001/archneur.63.9.1277.

Zetterberg, HL; (2006) The grammar of social science. Acta Sociologica , 49 (3) pp. 245-256. 10.1177/0001699306067706.

This list was generated on Sun Jun 18 04:16:22 2017 BST.